Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoLatham & Watkins Advises on US$911 Million Financing for 425 Park Ave.Read MoreFacebookX.comPinterestLinkedinEmail768150
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoLatham Advises UniCredit on €500 Million Syndicated Loan for Nemetschek GroupRead MoreFacebookX.comPinterestLinkedinEmail781150
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoLatham & Watkins Advises Alkermes on Sale of Athlone, Ireland Facility to Novo NordiskRead MoreFacebookX.comPinterestLinkedinEmail793150
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoLinklaters advises Atalaya Mining PLC on its step-up from AIM to LSE Main MarketRead MoreFacebookX.comPinterestLinkedinEmail784150
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteHNitya VashishthaDeals1 year agoHerbert Smith Freehills advises PsiQuantum on build of world-first utility-scale, fault-tolerant quantum computer in AustraliaRead MoreFacebookX.comPinterestLinkedinEmail792150
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoHerbert Smith Freehills advises Spartan on its A$80 million equity raiseRead MoreFacebookX.comPinterestLinkedinEmail789150
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoFreshfields Advises Zuora, Inc. on Its Acquisition of Togai Inc.Read MoreFacebookX.comPinterestLinkedinEmail780150
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoFreshfields advises ZF Friedrichshafen on $1.5bn notes issueRead MoreFacebookX.comPinterestLinkedinEmail787150
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoClifford Chance advises Actis on joint venture with Fortescue to develop major green hydrogen project in OmanRead MoreFacebookX.comPinterestLinkedinEmail779150
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoClifford Chance advises ESTEVE on its binding offer for the acquisition of HRA Pharma Rare DiseasesRead MoreFacebookX.comPinterestLinkedinEmail789150
